This brand name is authorized in Austria, Croatia, Estonia, France, Ireland, Italy, Lithuania, Poland, Spain, UK.
The drug ROLUFTA contains one active pharmaceutical ingredient (API):
1
|
UNII
GE2T1418SV - UMECLIDINIUM
|
|
Umeclidinium is a long acting muscarinic receptor antagonist (also referred to as an anticholinergic). It is a quinuclidine derivative that is a muscarinic receptor antagonist with activity across multiple muscarinic cholinergic receptor subtypes. Umeclidinium bromide exerts its bronchodilatory activity by competitively inhibiting the binding of acetylcholine with muscarinic cholinergic receptors on airway smooth muscle. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| R03BB07 | R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BB Anticholinergics | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EE | Ravimiamet | 1742071, 1742082, 1742093 |
| ES | Centro de información online de medicamentos de la AEMPS | 1171174002 |
| FR | Base de données publique des médicaments | 67728692 |
| GB | Medicines & Healthcare Products Regulatory Agency | 391678 |
| IT | Agenzia del Farmaco | 045321015, 045321027, 045321039 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1082483, 1082484, 1082485 |
| PL | Rejestru Produktów Leczniczych | 100387119 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.